全文获取类型
收费全文 | 9495篇 |
免费 | 920篇 |
国内免费 | 220篇 |
专业分类
耳鼻咽喉 | 104篇 |
儿科学 | 395篇 |
妇产科学 | 179篇 |
基础医学 | 360篇 |
口腔科学 | 117篇 |
临床医学 | 1862篇 |
内科学 | 1832篇 |
皮肤病学 | 72篇 |
神经病学 | 400篇 |
特种医学 | 249篇 |
外科学 | 1091篇 |
综合类 | 1195篇 |
预防医学 | 1143篇 |
眼科学 | 170篇 |
药学 | 962篇 |
38篇 | |
中国医学 | 232篇 |
肿瘤学 | 234篇 |
出版年
2024年 | 11篇 |
2023年 | 272篇 |
2022年 | 277篇 |
2021年 | 553篇 |
2020年 | 638篇 |
2019年 | 575篇 |
2018年 | 519篇 |
2017年 | 503篇 |
2016年 | 440篇 |
2015年 | 426篇 |
2014年 | 763篇 |
2013年 | 748篇 |
2012年 | 576篇 |
2011年 | 553篇 |
2010年 | 406篇 |
2009年 | 432篇 |
2008年 | 392篇 |
2007年 | 408篇 |
2006年 | 309篇 |
2005年 | 244篇 |
2004年 | 258篇 |
2003年 | 227篇 |
2002年 | 153篇 |
2001年 | 121篇 |
2000年 | 92篇 |
1999年 | 102篇 |
1998年 | 67篇 |
1997年 | 48篇 |
1996年 | 53篇 |
1995年 | 65篇 |
1994年 | 39篇 |
1993年 | 35篇 |
1992年 | 45篇 |
1991年 | 42篇 |
1990年 | 26篇 |
1989年 | 26篇 |
1988年 | 21篇 |
1987年 | 26篇 |
1986年 | 18篇 |
1985年 | 25篇 |
1984年 | 22篇 |
1983年 | 12篇 |
1982年 | 15篇 |
1981年 | 12篇 |
1980年 | 10篇 |
1979年 | 9篇 |
1978年 | 7篇 |
1977年 | 5篇 |
1975年 | 4篇 |
1974年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目的 探讨丹青胶囊联合他扎罗汀倍他米松治疗银屑病的临床疗效.方法 选取2019年6月—2021年6月在天津市职业病防治院门诊皮肤科就诊治疗的114例银屑病患者,根据随机数字法分为对照组和治疗组,每组各57例.对照组患者给予他扎罗汀倍他米松乳膏,洗净患处,待皮肤干爽后,将适量本品均匀涂抹于患处,1次/d.治疗组患者在对照组治疗基础上口服丹青胶囊,4粒/次,3次/d.两组患者均连续治疗7 d.观察两组患者的临床疗效和临床症状好转时间,比较两组治疗前与治疗1、4、8周的皮损面积和严重程度指数(PASI)评分和血清炎性因子水平.结果 治疗后,治疗组总有效率是98.25%,显著高于对照组的82.46%(P<0.05).治疗后,治疗组患者皮损暗红、皮损肥厚、皮肤瘙痒、皮肤疼痛等症状好转时间均显著短于对照组(P<0.05).治疗后,两组PASI评分均较治疗前显著降低(P<0.05);治疗1、4、8周治疗组PASI评分显著低于对照组(P<0.05).治疗后,两组患者血清炎性因子白细胞介素6(IL-6)、白细胞介素17(IL-17)、肿瘤坏死因子α(TNF-α)、干扰素-γ(IFN-γ)水平均较治疗前显著降低(P<0.05);治疗后,治疗组血清炎性因子水平显著低于对照组(P<0.05).结论 丹青胶囊联合他扎罗汀倍他米松治疗银屑病效果明显,能显著降低炎性因子水平,并有助于改善皮损情况,值得临床推广应用. 相似文献
3.
《Journal of the American College of Radiology》2022,19(3):407-414
ObjectiveTo evaluate the impact of structured recommendations on follow-up completion for incidental lung nodules (ILNs).MethodsPatients with ILNs before and after implementation of structured Fleischner recommendations and electronic tracking were sampled randomly. The cohorts were compared for imaging follow-up. Multivariable logistic regression was used to assess appropriate follow-up and loss to follow-up, with independent variables including use of structured recommendations or tracking, age, sex, race, ethnicity, setting of the index test (inpatient, outpatient, emergency department), smoking history, and nodule features.ResultsIn all, 1,301 patients met final inclusion criteria, including 255 patients before and 1,046 patients after structured recommendations or tracking. Baseline differences were found in the pre- and postintervention groups, with smaller ILNs and younger age after implementing structured recommendations. Comparing pre- versus postintervention outcomes, 40.0% (100 of 250) versus 29.5% (309 of 1,046) of patients had no follow-up despite Fleischner indications for imaging (P = .002), and among the remaining patients, 56.6% (82 of 145) versus 75.0% (553 of 737) followed up on time (P < .001). Delayed follow-up was more frequent before intervention. Differences postintervention were mostly accounted for by nodules ≤8 mm in the outpatient setting (P < .001). In multivariable analysis, younger age, White race, outpatient setting, and larger nodule size showed significant association with appropriate follow-up completion (P < .015), but structured recommendations did not. Similar results applied for loss to follow-up.DiscussionConsistent use of structured reporting is likely key to mitigate selection bias when benchmarking rates of appropriate follow-up of ILN. Emergency department patients and inpatients are at high risk of missed or delayed follow-up despite structured recommendations. 相似文献
4.
5.
A. M. Crawford 《Anaesthesia》2023,78(11):1323-1326
6.
《Journal of Radiology Nursing》2022,41(4):264-268
Measuring outcomes in health care have become mandatory as regulatory agencies, institutional guidelines, employers, and consumer groups advocate for quality health care focusing on improving patient outcomes. System-level quality departments often provide a framework for performance improvement (PI) that supports the organizational PI plan. However, nurses must learn to lead and be actively involved in projects in the radiology department to ensure key performance indicators are developed with on-the-ground quality management to improve patient outcomes, system performance, and professional development. This article explores such efforts at a large women’s specialty hospital in the Southern United States. 相似文献
7.
《Saudi Pharmaceutical Journal》2022,30(2):108-111
Linezolid is an oxazolidinone antibiotic. Linezolid-associated lactic acidosis has been reported in 6.8% of linezolid-treated patients. Lactic acidosis is associated with poor clinical outcomes, with high blood lactate levels resulting in organ dysfunction and mortality. This case report describes the development of lactic acidosis in a 64-year-old Chinese woman who had received 33 days of treatment with antituberculosis drugs and 28 days of treatment with oral linezolid for tuberculous meningitis. Severe lactic acidosis was reversed by withdrawing antituberculosis drugs and using continuous venovenous hemodiafiltration (CVVH). When the patient's condition was stable, she was transferred to the infectious disease department, and antituberculosis drugs, with the exception of linezolid, were reintroduced. This did not result in recurrence of lactic acidosis. The causal relationship between lactic acidosis and linezolid was categorized as ‘probable’ on the Adverse Drug Reaction Probability Scale. This case demonstrates that CVVH has potential as an alternative to discontinuation of linezolid alone for rapid reversal of linezolid-associated severe lactic acidosis. 相似文献
8.
《Indian heart journal》2022,74(5):351-356
AimsIMPROVE Brady assessed whether a process improvement intervention could increase adoption of guideline-based therapy in sinus node dysfunction (SND) patients.Methods/Results: IMPROVE Brady was a sequential, prospective, quality improvement initiative conducted in India and Bangladesh. Patients with symptomatic bradycardia were enrolled. In Phase I, physicians assessed and treated patients per standard care. Phase II began after implementing educational materials for physicians and patients. Primary objectives were to evaluate the impact of the intervention on SND diagnosis and pacemaker (PPM) implant. SF-12 quality of life (QoL) and Zarit burden surveys were collected pre- and post-PPM implant.A total of 978 patients were enrolled (57.7 ± 14.8 years, 75% male), 508 in Phase I and 470 in Phase II. The diagnosis of SND and implantation of PPM increased significantly from Phase I to Phase II (72% vs. 87%, P < 0.001 and 17% vs. 32%, P < 0.001, respectively). Pacemaker implantation was not feasible in 41% of patients due to insurance/cost barriers which was unaltered by the intervention. Both patient QoL and caregiver burden improved at 6-months post-PPM implant (P < 0.001).ConclusionsA process improvement initiative conducted at centers across India and Bangladesh significantly increased the diagnosis of SND and subsequent treatment with PPM therapy despite the socio-economic constraints. 相似文献
9.
10.
目的 分析双水平气道正压双水平气道正压通气(bi-level positive airway pressure,BiPAP)对阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apnea hypopnea syndrome,OSAHS)患者血管内皮功能及预后的影响。
方法 将100例OSAHS患者纳入研究,随机分为观察及对照组,各50例。观察组行BiPAP
,对照组行常规治疗,比较两组多导睡眠监测(polysomnography,PSG)检查指标(低通气指数、呼吸暂停指数、呼吸暂停及低通气时间、90%以下血氧饱和度次数、90%以下血氧饱和度时间)、心肺功能[脑钠肽(brainnatriureticpeptide,BNP)、右心室Tei指数、左心室Tei指数、一秒用力呼气容积占用力肺活量的百分比(forced expiratory volume in one second/forced vital capacity,FEV1/FVC)、一秒用力呼气容积占预计值的百分比(FEV1占预计值%)]、血管内皮功能[内皮素1(endothelin-1,ET-1)、一氧化氮(nitric oxide,NO)、凝血酶Ⅲ(antithrombin Ⅲ,AT-Ⅲ)]及生活质量。
结果 观察组低通气指数、呼吸暂停指数、呼吸暂停及低通气时间、90%以下血氧饱和度次数及时间指标均显著低于对照组(P<0.05)。观察组治疗后BNP以及Tei指数显著低于治疗前及对照组治疗后,FEV1/FVC、FEV1占预计值%显著高于治疗前及对照组治疗后(P<0.05)。观察组治疗后ET-1、AT-Ⅲ低于治疗前及对照组治疗后,NO高于治疗前及对照组治疗后(P<0.05)。观察组治疗后生活质量各项目评分高于对照组(P<0.05)。
结论 BiPAP治疗能够改善OSAHS患者的预后情况及血管内皮功能,效果确切。 相似文献